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Abstract: The gram-negative bacterium Legionella dumoffii is, beside  
Legionella pneumophila, an etiological agent of Legionnaires’ disease, an atypical  
form of pneumonia. The aim of this study was to determine the antimicrobial activity of 
Galleria mellonella defense polypeptides against L. dumoffii. The extract of immune 
hemolymph, containing a mixture of defense peptides and proteins, exhibited a  
dose-dependent bactericidal effect on L. dumoffii. The bacterium appeared sensitive to a 
main component of the hemolymph extract, apolipophorin III, as well as to a defense 
peptide, Galleria defensin, used at the concentrations 0.4 mg/mL and 40 μg/mL, 
respectively. L. dumoffii cells cultured in the presence of choline were more susceptible to 
both defense factors analyzed. A transmission electron microscopy study of bacterial cells 
demonstrated that Galleria defensin and apolipophorin III induced irreversible cell wall 
damage and strong intracellular alterations, i.e., increased vacuolization, cytoplasm 
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condensation and the appearance of electron-white spaces in electron micrographs. Our 
findings suggest that insects, such as G. mellonella, with their great diversity of 
antimicrobial factors, can serve as a rich source of compounds for the testing of Legionella 
susceptibility to defense-related peptides and proteins. 
Keywords: phosphatidylcholine; Legionella; Galleria mellonella; apolipophorin III; 
Galleria defensin 
 
1. Introduction 
Legionellae are fastidious gram-negative bacteria found in moist natural environments as 
intracellular parasites of freshwater protozoa [1]. The bacteria also occur in man-made aquatic 
systems, which facilitate proliferation and dissemination of these bacteria by producing water-air 
aerosol. After transmission to humans, Legionella spp. can cause a pneumonia called Legionnaires’ 
disease. The majority of cases of Legionnaires’ disease are caused by Legionella pneumophila, but 
Legionella dumoffii is the fourth most common causative agent [2]. In humans, L. dumoffii causes even 
more serious and rapidly progressive types of pneumonia than that induced by other strains of 
Legionella [3]. Moreover, infection by L. dumoffii can contribute to other diseases, such as septic 
arthritis, pericarditis and prosthetic-valve endocarditis [4,5]. The ability of L. dumoffii to survive and 
multiply within protozoa [6,7] and in a human macrophage cell line has been described [8]. There are 
also suggestions that L. dumoffii can invade and proliferate in human alveolar epithelial cells [9]. To 
date, the mechanisms underlying the virulence and rapid progression of pneumonia due to L. dumoffii 
are poorly understood. 
As an intracellular pathogen, Legionella spp. has evolved multiple strategies needed to overcome or 
evade the defense system of the host cell. For example, after being phagocytosed by mammalian 
macrophages or amoebae, L. pneumophila resides in a phagosome, whose ability to fuse with 
lysosomes is virtually restricted. One of the most important compounds of the host defense  
system produced to kill the invading pathogens are cationic antimicrobial peptides. Human  
β-defensins (hBDs), the members of the β-defensin family that display antimicrobial and 
immunomodulatory properties, are probably the essential defense factors of epithelial mucosa and 
macrophages [10]. It was demonstrated that although extracellular L. pneumophila was resistant to the 
cationic peptide antibiotic—polymyxin B—it was sensitive to hBD-2 and hBD-3 defensins, suggesting 
that these peptides are directly involved in the defense against Legionella in humans [10,11]. 
From among one thousand eukaryotic antimicrobial peptides characterized to date, about 200 have 
been described in insects. Insects have developed a very effective innate immunity system in which 
invading pathogens are efficiently eliminated by antimicrobial peptides. There are three main classes 
of cationic defense peptides in insects: (i) α-helical peptides without cysteine residues, e.g., cecropins, 
(ii) peptides with a structure stabilized by disulfide bridges, e.g., defensins, and (iii) peptides with 
overrepresentation of one amino acid, e.g., apidaecins or drosocins [12]. The structure of most of the 
insect defensins, similarly to their human counterparts, is stabilized by three disulfide bridges formed 
by six cysteine residues. However, in contrast to hBDs containing an αβββ scaffold, the insect 
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defensins contain an αββ scaffold consisting of an α-helical domain and two anti-parallel β-strands in 
which the α-helix is stabilized by two disulfide bridges to one strand of the β-sheet. The insect 
defensins are active against various bacteria, yeasts and filamentous fungi; however, their activity 
towards Legionella has not been investigated [13]. Interestingly, Casteels et al. [14] presented 
evidence that insect proline-rich peptides, apidaecins, inhibited growth of L. pneumophila, indicating 
that other defense peptides, in addition to defensins, could be involved in overcoming  
Legionella infections. 
In hemolymph of the greater wax moth Galleria mellonella larvae, an impressive set of cationic 
defense peptides differing in biochemical and antimicrobial properties was reported: insect defensins, 
cecropins, moricins, gloverins and proline-rich peptides. In addition to many cationic ones, two 
anionic defense peptides were characterized in this insect [15–21]. Among eight peptides isolated by 
us from larval hemolymph and tested against selected gram-negative bacteria (Escherichia coli D31, 
E. coli ATCC 25922, Salmonella Typhimurium), only cecropin D-like peptide inhibited growth of  
E. coli D31 [17]. Apart from antimicrobial peptides, certain hemolymph proteins, such as hydrophobic 
apolipophorin III (apoLp-III), an insect homologue of human apolipoprotein E (apoE), also exhibited 
antibacterial activity. Both proteins apoLp-III and apoE, in addition to functioning in lipid transport, 
play an important role in immunity. It was reported that G. mellonella apoLp-III inhibited growth of 
gram-negative bacteria S. Typhimurium and Klebsiella pneumoniae [22–24], whereas apoE was 
demonstrated to be involved in immune response against K. pneumoniae and Listeria monocytogenes, 
as well as protection against a lethal dose of Salmonella minnesota LPS [25–29]. 
It has been documented that the antimicrobial properties of cationic defense peptides are dependent 
on their positive charge and amphipathicity, which enable interactions with negatively charged 
membrane phospholipids [30,31]. Our unpublished results demonstrated that cultivation of L. dumoffii 
on a medium supplemented with choline led to an increase in the phosphatidylcholine (PC) content in 
the bacterial cell membrane. In the present study, we demonstrate evidence of anti-L. dumoffii activity 
of two antimicrobial components of G. mellonella hemolymph, apoLp-III and Galleria defensin. In 
addition, to provide more insight into the mechanism of interaction of G. mellonella polypeptides with 
cells of L. dumoffii, the effect of an increased PC content in the cell membrane on the effectiveness of 
their antibacterial action was investigated. The effects of the action of polypeptides on bacterial cells 
were imaged by transmission electron microscopy. The results presented suggest that the selected 
defense peptides and proteins of G. mellonella could be used as a template for designing novel  
anti-L. dumoffii agents.  
2. Results 
2.1. The Effect of Extracts of Immune G. mellonella Hemolymph on L. dumoffii Survival Rate  
Our previous study reported that methanolic extracts of G. mellonella immune hemolymph contain 
an abundant hemolymph protein, apoLp-III, as a main component, and a set of defense peptides 
differing in biochemical and antimicrobial properties [17,32]. A preliminary study performed using a 
radial diffusion assay revealed inhibition of L. dumoffii growth by the G. mellonella immune 
hemolymph extract as a clear zone around the point of extract application (data not shown). Then, the 
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inhibitory effect of the extract on L. dumoffii cells was examined using a colony-counting  
assay (Figure 1). The extract reduced the survival rate of the bacteria in a dose-dependent manner in 
the total protein concentration range of 0.4–0.8 mg/mL. The bacteria survivability was decreased by 
more than 50% at the concentration 0.4 mg/mL of the total extract protein. With the increasing 
concentration of the protein, the bactericidal activity of the extract was enhanced, as only 25% of the 
bacteria survived at the protein concentration of 0.8 mg/mL (Figure 1). However, further increasing 
the protein concentration to 1.6 mg/mL reduced the bacteria survival only by another 5%, whereas  
3.3 mg/mL did not cause a further decrease in the bacteria survival rate, probably due to protein 
aggregation. The data presented were obtained after 1 h incubation of the bacteria in the presence of 
the hemolymph extract; however, the same bactericidal effect was observed already after 15 min of 
incubation of the bacteria with the extract (data not shown).  
Figure 1. Growth inhibition of L. dumoffii by G. mellonella immune hemolymph extract. 
The bacteria were incubated with the extract at the concentrations 0.4–3.3 mg/mL  
(total protein) for 1 h, as described in the Experimental Section. Next, the cells were 
seeded on the agar plates, and the growing colonies were counted. Survival of the untreated 
cells was regarded as 100% (C; control). Statistical significance: * p < 0.05; ** p < 0.01. 
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2.2. The Effect of G. mellonella Defensin and apoLp-III on Survival Rate of L. dumoffii Cultured with 
and without Choline Supplementation 
The activity of G. mellonella defensin and apoLp-III was tested against bacteria cultured on the 
non-supplemented, as well as choline-enriched, BCYE medium using a colony counting assay. The 
bacteria were incubated for 1 h in the presence of Galleria defensin in the final concentration range of 
4–40 μg/mL. The effect of apoLp-III, the main component of hemolymph extract, was also evaluated 
at the concentration of 0.4 mg/mL. The sensitivity of L. dumoffii to both G. mellonella antimicrobial 
factors is presented in Figure 2. The bacteria appeared moderately sensitive to Galleria  
defensin (40 μg/mL), as well as apoLp-III (0.4 mg/mL). Each of the factors decreased the survival rate 
of L. dumoffii by ca. 30%. For concentrations below the maximal tested, Galleria defensin and  
apoLp-III were not effective in killing L. dumoffii (data not shown). As apoLp-III constitutes the main 
component of the hemolymph extract, these results could explain the need for using relatively high 
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concentrations of the total extract protein in our experiments presented in Figure 1. Interestingly, 
increased sensitivity to both defense factors was observed when L. dumoffii cells were cultured in the 
presence of choline. As shown in Figure 2, Galleria defensin and apoLp-III were 3.8-fold  
and three-fold more active, respectively, against L. dumoffii in respect to bacteria grown on the  
non-supplemented medium.  
Figure 2. The effects of G. mellonella apoLp-III and defensin on L. dumoffii survival and 
influence of choline supplementation on the activity of the antimicrobial factors. The 
bacteria cultured on the non-supplemented (black bars) and choline-supplemented (grey bars) 
medium were exposed to Galleria defensin (40 μg/mL) or apoLp-III (0.4 mg/mL), as 
described in the Experimental Section. After seeding of the bacteria on the agar plates, the 
growing colonies were counted. Survival of the untreated cells was regarded as 100%  
(C; control). The results are given as mean ± SD from three independent experiments. 
Statistical significance: ** p < 0.01; *** p < 0.001. 
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2.3. Transmission Electron Microscope Observations of Legionella dumoffii 
2.3.1. The Changes in the L. dumoffii Cell Morphology under the Influence of G. mellonella Immune 
Hemolymph Extract 
To demonstrate the direct effect of the extract of G. mellonella hemolymph on L. dumoffii cell 
morphology, the bacterial cells were observed by transmission electron microscopy. Microscopic 
observations of control cells (non-treated with the extract) revealed presence of small vacuoles, well 
discernible outer and inner membrane and cytoplasm containing numerous ribosomes. The cells were 
of longitudinal shape. The bacilli were usually 1.5 to 2.0 μm in length and 0.4 to 0.5 μm in diameter, 
and no infolding of the cytoplasmic membrane (“mesosomes”) was seen (Figure 3A–C). No changes 
in the structure were demonstrated in cell morphology of bacteria cultured on the choline-supplemented 
medium. All their organelles still had a typical appearance (Figure 3D,E). Microscopic examination of 
the bacteria treated with the extract of G. mellonella hemolymph revealed the presence of severe  
cell envelope damage with apparent local widening and changes in the cytoplasm appearance  
(Figure 3F–I). The cytoplasm was often granular and denser in comparison to the cytoplasm of the 
control cells. An enlarged periplasmatic space accompanying a locally widened envelope membrane 
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was noted (Figure 3F,H). After the exposure of L. dumoffii to the G. mellonella extract, the shape of 
the bacteria was also modified. Additionally, loose attachment of the cell membrane was visible 
(arrows). The vacuoles were electron-lucent and surrounded by an electron-dense membrane 
(arrowheads) (Figure 3G,H). Similar changes, especially in the cell wall, were observed in bacterial 
cells cultured on the choline-supplemented medium after exposure to the G. mellonella extract. 
Distortion and loss of the cell wall in some parts of the cells were noted (Figure 3J,K). 
Figure 3. The influence of the extract of G. mellonella immune hemolymph on L. dumoffii 
cell morphology. The cells growing on the non-supplemented (A–C,F–I) and  
choline-supplemented (D,E,J–K) agar medium were exposed to G. mellonella hemolymph 
extract (F–I,J,K) or left untreated (A–C,D,E). Then, the cells were prepared for TEM 
analysis as described in the Experimental Section. (A) one big bacterium in longitudinal 
section; vacuoles are visible inside the cell (arrowheads); the outer and inner membrane is 
distinguishable in the cell envelope; (B) a fragment of the bacterium with a visible internal 
membrane (arrows); IM, inner membrane; OM, outer membrane; (C) a portion of the 
bacterium with a peptidoglycan-like layer (denoted as PG); outer and inner membranes are 
seen; (D,E) cells cultured on the choline-supplemented medium with a typical appearance; 
(F) cells showing cell wall damage and a periplasmatic space (arrows); (G) bacteria with 
cell wall damage (arrows) and dense cytoplasm with vacuoles (arrowhead); (H) enlarged 
view of a bacterium with strong cell envelope damage and cytoplasm condensation; the 
rest of the cells exhibit cell wall damage and presence of vacuoles (arrowhead); (I) many 
bacterial cells demonstrating loose attachment of the cell membrane (arrows); and  
(J,K) cells cultured on choline exposed to the extract with visible deterioration of the  
cell wall. 
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2.3.2. Ultrastructural Changes in the Cells of L. dumoffii after Treatment with Defensin and apoLp-III 
Isolated from G. mellonella Hemolymph 
In the subsequent stage of the microscopic examination, the bacteria cultured on the  
non-supplemented and choline-enriched medium were treated with purified Galleria defensin or 
apoLp-III. The microscopic observations revealed significant changes in the ultrastructural 
characteristics of L. dumoffii exposed to apoLp-III, such as the presence of many vacuoles within the 
cytoplasm and minor changes in the cell envelope structure (Figure 4). In various parts of the cell, the 
cytoplasm was condensed and, additionally, regions with decreased electron density were detected 
(Figure 4A–C). The cells cultured on the choline-supplemented medium also revealed vacuolization of 
the cytoplasm after the treatment with apoLp-III. However, the cell envelope damage was greater than 
in the cells exposed to apoLp-III, but cultured on the medium without choline supplementation. Some 
cells exhibited a widened periplasmatic space (Figure 4D–F). Distinct changes were observed in the 
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ultrastructure of cells treated with Galleria defensin and apoLp-III. Defensin treatment of L. dumoffii 
cells considerably affected the cell morphology of L. dumoffii, and the loss of typical subcellular 
organization was detected. Within the cytoplasm, large electron-white spaces (vacuole-like spaces), as 
well as highly condensed areas, were observed. Substantial, irreversible (lethal) cell wall damage was 
noticed. Some cells were shrunk, with a very dense content and barely discernible cell envelope  
(Figure 4G,H). The cells of bacteria cultured on the choline-enriched medium showed substantial 
changes due to Galleria defensin treatment. Cell shrinkage, condensation of cytoplasm and loss of cell 
envelope integrity were followed by the appearance of small vacuoles surrounded by an electron-dense 
membrane in numerous shrunken cells (Figure 4I). In cells larger in size, further destruction occurred, 
such as deprivation of the cell wall structure and the appearance of electron-white regions. 
Additionally, small vacuoles were visible in the dense cytoplasm (Figure 4J,K).  
Figure 4. The influence of defensin and apolipophorin III isolated from G. mellonella 
hemolymph on the ultrastructure of L. dumoffii cells. The cells grown on the  
non-supplemented (A–C,G,H) and choline-supplemented (D–F,I–K) medium were 
incubated in the presence of apoLp-III (A–F) or Galleria defensin (G–K). Then the cells 
were prepared for TEM analysis as described in the Experimental Section. (A,B) cells 
showing condensed cytoplasm, regions with decreased electron density and the presence of 
vacuoles (arrowhead); (C) a fragment of the bacterium with a group of visible vacuoles 
and dark, dense cytoplasm; (D,E) cells with vacuolization features (arrowheads) and cell 
envelope damage (arrow); (F) bacteria with cell wall distortion (arrow) and a widened 
periplasmatic space; (G) cells with electron-white spaces (EWS), membrane deterioration 
(arrows), and condensed content (arrowheads); (H) irreversible cell wall damage visible in 
bacteria (arrows) together with dense areas of cytoplasm or entire cytoplasm of the whole 
cells (arrowheads); (I) bacteria demonstrating loss of cell wall integrity, vacuolization of 
cytoplasm (arrowheads), cell shrinkage; and (J,K) cells showing cell wall damage 
(arrows), electron-white spaces (EWS), presence of small vacuoles (arrowheads). 
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3. Discussion 
In the present study, the effects of G. mellonella defense peptides and proteins, essential 
components of insect immune response, on the viability of L. dumoffii were investigated. To the best 
of our knowledge, this is the first report on the antibacterial activity of insect defense factors against 
this species of Legionella. L. dumoffii was found to be sensitive to Galleria defensin. The inhibitory 
effect of Galleria defensin on L. dumoffii is the first evidence of the antibacterial activity of this 
peptide. In previous studies, only the antifungal activity of Galleria defensin was reported [15,17]. 
Recently, G. mellonella larvae have been exploited as a model system to study L. pneumophila 
pathogenicity, however, susceptibility of the bacteria to G. mellonella antimicrobial proteins and 
peptides has not been tested [33]. Interestingly, infection of the larvae by L. pneumophila upregulated 
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expression of Galleria defensin, suggesting involvement of this peptide in anti-Legionella response, 
which is consistent with our results demonstrating its anti-Legionella activity in vitro.  
Antibacterial activity of G. mellonella apoLp-III against selected bacteria (Bacillus circulans,  
S. Typhimurium, K. pneumoniae) was reported in our previous papers [23,24]. Inhibition of  
L. dumoffii growth by apoLp-III is another piece of evidence for the antibacterial activity of this insect 
protein. Moreover, susceptibility of L. dumoffii to apoLp-III could suggest involvement of its human 
homologue, apoE, in anti-Legionella defense in humans.  
Like other Legionella species (L. pneumophila, L. bozemanae, L. lytica), L. dumoffii utilizes 
extracellular choline for the synthesis of phosphatidylcholine (PC)—an important constituent of the 
cell envelope [34,35]. PC is primarily a component of membrane lipids in eukaryotic cells; only 15% 
of bacteria, mainly photosynthetic bacteria with an extensive internal membrane structure or the host 
cell-associated bacteria (either pathogenic or symbiotic), contain this phospholipid in their cell 
envelope. Aside from the role in membrane assembly, PC functions also as a modulator of a wide 
variety of cellular pathways. Exposure of phosphocholine groups, characteristic for bacteria residing 
predominantly in the respiratory tract, allows the bacteria to interact with the platelet-activating  
factor (PAF) receptor of the host and, consequently, to invade the epithelial cells [36].  
In our experiments, the supplementation of L. dumoffii culture with choline led to the significantly 
increased susceptibility of the bacteria to apoLp-III and Galleria defensin. The results indicated the 
relationship between the increased content of the phospholipid in the bacterial cell membrane and the 
effectiveness of antimicrobial activity of the G. mellonella defense compounds tested. One could 
suggest enhanced binding of both defense factors to the cells of L. dumoffii grown in the presence of 
choline. Due to the fact that PC represents zwitterionic phospholipids, it seems that the interaction of 
Galleria defensin, as well as apoLp-III with L. dumoffii cells, was enhanced mainly by the increased 
hydrophobic properties of the bacterial cell envelope. Moreover, one could postulate PC to be a 
receptor for binding these G. mellonella defense factors to the L. dumoffii cell membrane. For 
example, it was reported that molecules of the synthetic antimicrobial peptide cecropin B3 containing 
two hydrophobic α-helical segments, clustered in the domains of the membrane enriched in lipids with 
neutral headgroups, such as PC [37]. It was also suggested that phosphorylcholine decorations may 
change the sensitivity of Haemophilus influenzae bacteria to the antimicrobial activity of the human 
peptide LL-37/hCAP18 [38]. Recently, it has been reported that the increase of branched-chain fatty 
acids and the decrease of fatty acid chain length in the L. pneumophila membrane were correlated with 
the increased resistance of the bacteria to warnericin RK, an amphiphilic α-helical antimicrobial 
peptide produced by Staphylococcus werneri [39]. Hence, sensitivity of the bacteria to antimicrobial 
peptides and proteins would be, at least in part, modulated by the membrane fatty acid composition. 
In gram-negative bacteria, such as S. Typhimurium and Pseudomonas aeruginosa, antimicrobial 
peptides comprise environmental signals sensed by two-component systems, PhoPQ, PmrAB and 
ParRS, respectively. Activation of these systems is responsible for the regulation of gene expression, 
leading to LPS modification and adaptive resistance to cationic antimicrobials [40–42]. In Legionella, 
regulation of LPS modification genes by two-component systems has not been yet reported, however a 
role for the PmrAB system in the regulation of several genes encoding Dot/Icm-secreted effectors  
has been shown recently in L. pneumophila [43]. In addition, the involvement of the rcp gene in  
L. pneumophila resistance to antimicrobial peptides and polymyxin B has been demonstrated [44]. Rcp 
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protein exhibits strong sequence and functional homology to S. Typhimurium PagP protein, acting as a 
palmitoyl transferase able to modify the lipid A component of LPS by the addition of fatty acid 
palmitate. Such modification is believed to promote resistance to cationic antimicrobial peptides by 
decreasing membrane fluidity and preventing insertion of the peptides. It is possible that Rcp protein 
plays a similar role in L. pneumophila [44]. Taking this into consideration, the lower susceptibility of 
L. dumoffii cells cultured without choline supplementation to G. mellonella defense factors reported in 
our study could imply sensing of the antimicrobial peptides by L. dumoffii cells and induction of 
expression of genes involved in the bacteria response to these molecules. Explanation of the impact of 
antimicrobial peptides on transcriptional regulation of the virulence factors in Legionella requires 
further detailed investigations. The destructive effect of the extract of G. mellonella hemolymph, 
apoLp-III and defensin on L. dumoffii cell morphology was observed by transmission electron 
microscopy. The differences between the ultrastructural changes induced by apoLp-III and by Galleria 
defensin are possibly related to the diverse mechanisms of action of these polypeptides against  
L. dumoffii. Further experimental investigations are needed to explain the mode of action of apoLp-III 
and Galleria defensin on the cells of L. dumoffii and the role of PC in bacterial sensitivity to  
these compounds.  
4. Experimental Section 
4.1. Bacterial Strain and Culture Conditions 
L. dumoffii, strain ATCC 33279 was kindly supplied by Dr. B. Fields and Dr. E. Brown from CDC 
Atlanta (GA, USA). The bacteria were cultured for three days at 37 °C in humid atmosphere and  
5% CO2 on buffered charcoal yeast extract (BCYE) agar supplemented with the Growth Supplement  
SR110 (Oxoid, Basingstoke, Hampshire, UK) [45]. For growth of bacteria on the choline-enriched 
medium, BCYE agar was supplied with 100 μg/mL choline chloride (Sigma-Aldrich, Chemical Co.,  
St. Louis, MO, USA). The bacteria collected from this medium were washed three times with water by 
intensive vortexing and centrifugation at 8000× g for 10 min. 
4.2. Insect Culture and Immune Challenge 
Larvae of the greater wax moth G. mellonella (Lepidoptera: Pyralidae) were reared on a natural  
diet—honeybee nest debris at 30 °C in the dark. Last instar larvae (250–300 mg in weight) were used 
throughout the study. For immune challenge, the larvae were pierced with a needle dipped into a pellet 
of viable E. coli D31 and Micrococcus luteus ATCC 10240 cells. The larvae were kept at 30 °C in the 
dark, and the hemolymph was collected 24 h after the treatment. 
4.3. Preparation of Methanolic Extracts of G. mellonella Hemolymph 
Acidic/methanolic extracts were prepared from the hemolymph of immune-challenged  
G. mellonella larvae. The cell-free hemolymph was diluted ten times with an extraction solution 
consisting of methanol:glacial acetic acid:water (90:1:9 v/v/v). Precipitated proteins were pelleted by 
centrifugation at 20,000× g for 30 min at 4 °C. The supernatant obtained was collected and  
freeze-dried, and the resulting lyophilisate was dissolved in 0.1% trifluoroacetic acid (TFA). For 
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removal of lipids from the extract, the same volume of n-hexane was added, and the sample was 
vortexed and centrifuged at 20,000× g for 10 min at 4 °C. The upper fraction containing lipids was 
removed, and an equal volume of ethyl acetate was added. After vortexing and centrifugation, the 
water fraction was freeze-dried and stored at −20 °C until use. For the experiments, the extracts were 
dissolved in apyrogenic water (2/3 volume of hemolymph). The hemolymph extracts contained 
proteins with a molecular weight below 30 kDa (mainly apoLp-III) and defense peptides, as 
demonstrated in our previous paper [17]. 
4.4. Purification of G. mellonella Defense Peptides and Proteins 
The defense peptides and proteins were purified from the methanolic extracts of the  
immune-challenged G. mellonella larvae hemolymph according to the modified methods described 
previously by Cytryńska et al. [17]. The lyophilized and deprived of lipids immune hemolymph extract 
was reconstituted in 0.1% (v/v) trifluoroacetic acid (TFA) and subjected to the first step of purification 
using a Discovery Bio Wide Pore C18 250 mm × 4.6 mm column (Sigma) and a two buffer  
set: A: 0.1% TFA (v/v), B: 0.07% TFA, 80% acetonitrile (v/v). The linear 30%–70% gradient of  
buffer B over 35 min, 1 mL/min flow rate, and spectrophotometric detection at 220/280 nm was 
applied. This and all the following chromatographic steps were performed on a P680 HPLC  
system (Dionex, Munchen, Germany). Six consecutive fractions were collected: anionic peptide 1, 
lysozyme, a mixture of proline rich peptide 2 and apolipophoricin, Galleria defensin, a mixture of 
anionic peptide 2 and cecropin D-like peptide, as well as apolipophorin III. The fraction containing 
apolipophorin III was homogenous and was used without further purification. The fraction containing 
Galleria defensin was rechromatographed using the same column as above and the 39%–42% of 
buffer B over 25 min. The purity and identity of the collected fractions were confirmed by SDS-PAGE 
electrophoresis and N-terminal sequencing. In brief, the electrophoresis was performed according to 
the method of Schägger and von Jagow [46], the gel obtained was electroblotted onto a polyvinylidene 
difluoride (PVDF) membrane (Immobilon PSQ, Millipore, Billerica, MA, USA) stained with 
Coomassie Brillant Blue R-250, and then the peptides were identified by Edman degradation on a 
Procise 491 automatic protein sequencer (Applied Biosystems, Foster City, CA, USA). Purified 
Galleria defensin and apoLp-III were freeze-dried and stored at −20 °C until use. Before antimicrobial 
activity tests, they were dissolved in apyrogenic water. 
4.5. Anti-Legionella Activity Assays 
4.5.1. Radial Diffusion Assay  
Ten MicroLitre (µL) of bacterial suspension adjusted to an optical density at 600 nm (OD620) of 0.1 
was placed on a BCYE agar and 5 μL of the G. mellonella hemolymph extract containing 0.125 mg of 
total protein, were applied centrally. After a three-day incubation of the plates at 37 °C, the bacterial 
growth inhibition zone, as a clear zone around the point of the extract application, was evaluated. 
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4.5.2. Colony Counting Assay 
Ten-fold serial dilutions were made till a dilution of 10−4 from the bacterial suspension of an optical 
density OD620 of 0.1 corresponding to 2 × 108 cells/mL. Next, 5μL of the last dilution was transferred 
into sterile Eppendorf tubes and the G. mellonella hemolymph extract, purified apoLp-III or Galleria 
defensin to the final concentration in the range 0.4–3.3 mg/mL, 0.4 mg/mL and 4–40 μg/mL, 
respectively, were added. The bacteria were preincubated with the hemolymph extract or the 
polypeptides for 1 h at 37 °C, and then placed on the BCYE plates. After a three-day incubation  
at 37 °C, the grown colonies were counted. The experiments with bacteria cultured on  
choline-enriched medium were performed in the same way. All the experiments were conducted in 
three replicates. The results were referred to the controls defined as the total (100%) survival of  
L. dumoffii cells incubated in water without the addition of the hemolymph extract or polypeptides 
under the same conditions. 
4.6. Preparation of Samples for Microscopic Analysis 
The bacteria growing at the periphery of the clear growth inhibition zones were used for microscope 
observations of the effects exerted on L. dumoffii cell morphology by the G. mellonella hemolymph 
extract. As the control, the bacterial cells, well growing in a form of turf at a distance of 2 cm from the 
edge of the growth inhibition zone, were collected from the same agar plate. In order to check the 
influence of particular peptides, Galleria defensin or apoLp-III at the final concentration of 40 μg/mL 
or 0.4 mg/mL, respectively, were added to four tubes containing 50 μL of suspension of bacteria 
cultured on BCYE of an OD620 of 0.1 and to four tubes containing bacteria that were cultured on  
choline-supplemented BCYE of the same optical density. After a 1 h incubation at 37 °C, the 
suspensions incubated in the presence of the particular factors were pooled and centrifuged at 8000× g 
for 10 min. The resulting bacterial pellets were used for microscopic analyses. 
4.7. Transmission Electron Microscopy Analysis of L. dumoffii Cells 
The bacterial cells exposed to G. mellonella hemolymph extract were gently scraped from the agar 
surface using the microbiological loop and collected into the vials containing 2% formaldehyde 
(freshly prepared from paraformaldehyde) and 2.5% glutaraldehyde dissolved in 0.1 M sodium 
cacodylate buffer (pH 7.4). Then, the cell suspension was centrifuged at 8000× g for 10 min. The cell 
pellets were fixed for 24 h at 4 °C in buffered glutaraldehyde and formaldehyde (2.5% and 2%, 
respectively). After rinsing several times with 0.1 M cacodylate buffer (pH 7.4), the cell pellets were 
post-fixed in a 1% osmium tetroxide solution in 0.1 M sodium cacodylate buffer (pH 7.4) for 2 h  
at 4 °C. The bacterial cells were dehydrated in a series of alcohol and acetone and embedded in LR 
White resin. Ultrathin sections (65 nm) were cut with a diamond knife on a microtome RMC MT-XL 
(Boeckeler Instruments, Tucson, AZ, USA) collected on copper grids and contrasted with the use of 
uranyl acetate and Reynold’s liquid. The samples were observed under a LEO-Zeiss 912 AB electron 
microscope (Carl Zeiss Microscopy, Oberkohen, Germany). 
After incubation with the polypeptides, the bacterial pellets were flooded with the first fixative  
(the same as above described). The next steps of the procedure were performed as above described. 
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4.8. Other Methods 
The concentration of protein in the hemolymph was determined using the Bradford method and 
bovine serum albumin as a standard [47]. The quantity of apoLp-III was determined by weight, while 
the concentration of defensin was measured by amino acid analysis [48].  
4.9. Statistical Analysis 
Each experiment was performed at least three times. The experimental values are given as  
means ± SD. The statistical significance of the differences between the control and test values was 
evaluated using Student’s t-test. 
5. Conclusions 
In conclusion, (1) G. mellonella defense factors, defensin and apoLp-III exhibited anti-L. dumoffii 
activity, (2) L. dumoffii growing on choline-supplemented medium were more sensitive to defensin 
and apoLp-III, (3) the destructive effect of defense factors studied on bacterial cell morphology was 
evident in TEM images, and (4) our results indicate that insects, such as G. mellonella, with their great 
diversity of antimicrobial factors of different biochemical properties can serve as a rich source of 
compounds for testing of Legionella susceptibility to the defense-related peptides and proteins. 
Acknowledgements 
The authors acknowledge Barry Fields and Ellen Brown (CDC, Atlanta, GA, USA) for supplying 
the experimental bacteria. The authors thank Teresa Jakubowicz (Department of Immunobiology,  
Maria Curie-Sklodowska University, Lublin, Poland) and Teresa Urbanik-Sypniewska (Department of 
Genetics and Microbiology, Maria Curie-Sklodowska University, Lublin, Poland) for critical reading 
of and comments to the manuscript.  
This work was supported by the grant from the Ministry of Science and Higher Education  
No.N N303 822640. The research was partially carried out with equipment purchased through 
European Union structural funds (grants POIG.02.01.00-12-064/08 and POIG.02.01.00-12-167/08). 
Conflict of Interest 
The authors declare no conflict of interest. 
References 
1. Fields, B.S.; Benson, R.F.; Besser, R.E. Legionella and Legionnaires’ disease: 25 years of 
investigation. Clin. Microbiol. Rev. 2002, 15, 506–526. 
2. Yu, V.L.; Plouffe, J.F.; Pastoris, M.C.; Stout, J.E.; Schousboe, M.; Widmer, A.; Summersgill, J.; 
File, T.; Heath, C.M.; Paterson, D.L.; et al. Distribution of Legionella species and serogroups 
isolated by culture in patients with sporadic community-acquired legionellosis: An international 
collaborative survey. J. Infect. Dis. 2002, 186, 127–128. 
Int. J. Mol. Sci. 2012, 13 17062 
 
3. Fujita, I.; Tsuboi, H.; Ohotsuka, M.; Sano, I.; Murakami, Y.; Akioka, H.; Hayashi, M.  
Legionella dumoffii and Legionella pneumophila serogroup 5 isolated from 2 cases of fulminant 
pneumonia. J. Jpn. Assoc. Infect. Dis. 1989, 63, 801–810.  
4. Flendrie, M.; Jeurissen, M.; Franssen, M.; Kwa, D.; Klaassen, C.; Vos, F. Septic arthritis caused 
by Legionella dumoffii in a patient with systemic lupus erythematosus-like disease. J. Clin. 
Microbiol. 2011, 49, 746–749. 
5. Tompkins, L.S.; Roessler, B.J.; Redd, S.C.; Markowitz, L.E.; Cohen, M.L. Legionella  
prosthetic-valve endocarditis. N. Engl. J. Med. 1988, 318, 530–535. 
6. Neumeister, B.; Schoniger, S.; Faigle, M.; Eichner, M.; Dietz, K. Multiplication of different 
Legionella species in Mono Mac 6 cells and in Acantamoeba castellanii. Appl. Environ. 
Microbiol. 1997, 63, 1219–1224. 
7. Wadowsky, R.M.; Wilson, T.M.; Kapp, N.J.; West, A.J.; Kuchta, J.M.; States, S.J.;  
Dowling, J.N.; Yee, R.B. Multiplication of Legionella spp. in tap water containing Hartmannella 
vermiformis. Appl. Environ. Microbiol. 1991, 57, 1950–1955. 
8. O’Connell, W.A.; Dhand, L.; Cianciotto, N.P. Infection of macrophage-like cells by Legionella 
species that have not been associated with disease. Infect. Immun. 1996, 64, 4381–4384. 
9. Maruta, K.; Miyamoto, H.; Hamada, T.; Ogawa, M.; Taniguchi, H.; Yoshida, S.I. Entry and 
intracellular growth of Legionella dumoffii in alveolar epithelial cells. Am. Respir. Crit. Care Med. 
1998, 157, 1967–1974. 
10. Scharf, S.; Vardarova, K.; Lang, F.; Schmeck, B.; Opitz, B.; Flieger, A.; Heuner, K.;  
Hippenstiel, S.; Suttorp, N.; N’Guessan, P.D. Legionella pneumophila induces human beta 
Defensin-3 in pulmonary cells. Respir. Res. 2010, 11, 93. 
11. Scharf, S.; Hippenstiel, S.; Flieger, A.; Suttorp, N.; N’Guessan, P.D. Induction of human  
β-defensin-2 in pulmonary epithelial cells by Legionella pneumophila: Involvement of TLR2 and 
TLR5, p38 MAPK, JNK, NF-κB, and AP-1. Am. J. Physiol. Lung Cell Mol. Physiol. 2010, 298, 
687–695. 
12. Bulet, P.; Stöcklin, R. Insect antimicrobial peptides: Structures, properties and gene regulation. 
Prot. Pept. Lett. 2005, 12, 3–11. 
13. Bulet, P.; Stöcklin, R.; Menin, L. Anti-microbial peptides: From invertebrates to vertebrates. 
Immunol. Rev. 2004, 198, 169–184. 
14. Casteels, P.; Romagnolo, J.; Castle, M.; Casteels-Josson K.; Erdjument-Bromage, H.; Tempst, P. 
Biodiversity of apidaecin-type peptide antibiotics. J. Biol. Chem. 1994, 269, 26107–26115. 
15. Lee, Y.S.; Yun, E.K.; Jang, W.S.; Kim, I.; Lee, J.H.; Park, S.Y.; Ryu, K.S.; Seo, S.J.; Kim, C.H.; 
Lee, I.H. Purification, cDNA cloning and expression of an insect defensin from the great wax 
moth, Galleria mellonella. Insect. Mol. Biol. 2004, 13, 65–72. 
16. Kim, C.H.; Lee, J.H.; Kim, I.; Seo, S.J.; Son, S.M.; Lee, K.Y. Purification and cDNA cloning of a 
cecropin-like peptide from the great wax moth, Galleria mellonella. Mol. Cells 2004, 17,  
262–266. 
17. Cytryńska, M.; Mak, P.; Zdybicka-Barabas, A.; Suder, P.; Jakubowicz T. Purification and 
characterization of eight peptides from Galleria mellonella immune hemolymph. Peptides 2007, 
28, 533–546. 
Int. J. Mol. Sci. 2012, 13 17063 
 
18. Brown, S.E.; Howard, A.; Kasprzak, A.B.; Gordon, K.H.; East, P.D. The discovery and analysis 
of a diverged family of novel antifungal moricin-like peptides in the wax moth  
Galleria mellonella. Insect Biochem. Mol. Biol. 2008, 38, 201–212. 
19. Brown, S.E.; Howard, A.; Kasprzak, A.B.; Gordon, K.H.; East, P.D. A peptidomic study reveals 
the impressive antimicrobial peptide arsenal of the wax moth Galleria mellonella. Insect 
Biochem. Mol. Biol. 2009, 39, 792–800. 
20. Schuhmann, B.; Seitz, V.; Vilcinskas, A.; Podsiadlowski, L. Cloning and expression of 
gallerimycin, an antifungal peptide expressed in immune response of greater wax moth larvae, 
Galleria mellonella. Arch. Insect Biochem. Physiol. 2003, 53, 125–133. 
21. Mak, P.; Chmiel, D.; Gacek, G.J. Antibacterial peptides of the moth Galleria mellonella. Acta 
Biochim. Pol. 2001, 48, 1191–1195. 
22. Weers, P.M.; Ryan, R.O. Apolipophorin III: Role model apolipoprotein. Insect Biochem. Mol. 
Biol. 2006, 36, 231–240. 
23. Zdybicka-Barabas, A.; Cytryńska, M. Involvement of apolipophorin III in antibacterial defense of 
Galleria mellonella larvae. Comp. Biochem. Physiol. B 2011, 158, 90–98. 
24. Zdybicka-Barabas, A.; Januszanis, B.; Mak, P.; Cytryńska, M. An atomic force microscopy study 
of Galleria mellonella apolipophorin III effect on bacteria. Biochim. Biophys. Acta 2011, 1808, 
1896–1906. 
25. Hatters, D.M.; Peters-Libeu, C.A.; Weisgraber, K.H. Apolipoprotein E structure: Insights into 
function. Trends Biochem. Sci. 2006, 31, 445–454. 
26. Mahley, R.W.; Rall, S.C., Jr. Apolipoprotein E: Far more than a lipid transport protein. Annu. 
Rev. Genomics Hum. Genet. 2000, 1, 507–537. 
27. De Bont, N.; Netea, M.G.; Demacker, P.N.M.; Verschueren, I.; Kullberg, B.J.; van Dijk, K.W.; 
van der Meer, J.W.; Stalenhoef, A.F. Apolipoprotein E knock-out mice are highly susceptible to 
endotoxemia and Klebsiella pneumoniae infection. J. Lipid Res. 1999, 40, 680–685. 
28. Roselaar, S.E.; Daugherty, A. Apolipoprotein E-deficient mice have impaired innate immune 
responses to Listeria monocytogenes in vivo. J. Lipid Res. 1998, 39, 1740–1743. 
29. Van Oosten, M.; Rensen, P.C.; van Amersfoort, E.S.; van Eck, M.; van Dam, A.M.;  
Brevé, J.J.; Vogel, T.; Panet, A.; van Berkel, T.J.; Kuiper, J. Apolipoprotein E protects against 
bacterial lipopolysaccharide-induced lethality. A new therapeutic approach to treat gram-negative 
sepsis. J. Biol. Chem. 2001, 276, 8820–8824. 
30. Nguyen, L.T.; Haney, E.F.; Vogel, H.J. The expanding scope of antimicrobial peptide structures 
and their modes of action. Trends Biotechnol. 2011, 29, 464–472. 
31. Teixeira, V.; Feio, M.J.; Bastos, M. Role of lipids in the interaction of antimicrobial peptides with 
membranes. Prog. Lipid Res. 2012, 51, 149–177. 
32. Mak, P.; Zdybicka-Barabas, A.; Cytryńska, M. A different repertoire of Galleria mellonella 
antimicrobial peptides in larvae challenged with bacteria and fungi. Dev. Comp. Immunol. 2010, 
34, 1129–1136. 
33. Harding, C.R.; Schroeder, G.N.; Reynolds, S.; Kosta, A.; Collins, J.W.; Mousnier, A.; Frankel, G. 
Legionella pneumophila pathogenesis in the Galleria mellonella infection model. Infect. Immun. 
2012, 80, 2780–2790. 
Int. J. Mol. Sci. 2012, 13 17064 
 
34. Palusinska-Szysz, M.; Kalitynski, R.; Russa, R.; Dawidowicz, A.L.; Drozanski, W.J. Cellular 
envelope phospholipids from Legionella lytica. FEMS Microbiol. Lett. 2008, 283, 239–246. 
35. Palusinska-Szysz, M.; Janczarek, M.; Kalitynski, R.; Dawidowicz, A.L.; Russa, R.  
Legionella bozemanae synthesizes phosphatidylcholine from exogenous choline. Microbiol. Res. 
2011, 166, 87–98. 
36. Martínez-Morales, F.; Schobert, M.; López-Lara, I.M.; Geiger, O. Pathways for 
phosphatidylcholine biosynthesis in bacteria. Microbiology 2003, 149, 3461–3471. 
37. Wang, W.; Smith, D.K.; Moulding, K.; Chen, H.M. The dependence of membrane permeability 
by the antibacterial peptide cecropin B and its analogs, CB-1 and CB-3, on liposomes of different 
composition. J. Biol. Chem. 1998, 273, 27438–27448. 
38. Lysenko, E.S.; Gould, J.; Bals, R.; Wilson, J.; Weiser, J. Bacterial phosphorylcholine decreases 
susceptibility to the antimicrobial peptide LL-37/hCAP18 expressed in the upper respiratory tract. 
Infect. Immun. 2000, 68, 1664–1671. 
39. Verdon, J.; Labanowski, J.; Sahr, T.; Ferreira, T.; Lacombe, C.; Buchrieser, C.; Berjeaud, J.M.; 
Héchard, Y. Fatty acid composition modulates sensitivity of Legionella pneumophila to 
warnericin RK, an antimicrobial peptide. Biochim. Biophys. Acta 2011, 1808, 1146–1153. 
40. Koprivnjak, T.; Peschel, A. Bacterial resistance mechanisms against host defense peptides.  
Cell. Mol. Life Sci. 2011, 68, 2243–2254. 
41. Skiada, A.; Markogiannakis, A.; Plachouras, D.; Daikos, G.L. Adaptive resistance to cationic 
compounds in Pseudomonas aeruginosa. Int. J. Antimicrob. Agents 2011, 37, 187–193. 
42. Richards, S.M.; Strandberg, K.L.; Conroy, M.; Gunn, J.S. Cationic antimicrobial peptides serve as 
activation signals for the Salmonella Typhimurium PhoPQ and PmrAB regulons in vitro and  
in vivo. Front. Cell. Infect. Microbiol. 2012, 2, doi:10.3389/fcimb.2012.00102. 
43. Al-Khodar, S.; Kalachikov, S.; Morozova, I.; Price, C.T.; Abu Kwaik, Y. The PmrA/PmrB  
two-component system of Legionella pneumophila is a global regulator required for intracellular 
replication within macrophages and protozoa. Infect. Immun. 2009, 77, 374–386. 
44. Robey, M.; O’Connell, W.; Cianciotto, N.P. Identification of Legionella pneumophila rcp, a 
pagP-like gene that confers resistance to cationic antimicrobial peptides and promotes 
intracellular infection. Infect. Immun. 2001, 69, 4276–4286. 
45. Edelstein, P.H. Improved semiselective medium for isolation of Legionella pneumophila from 
contaminated clinical and environmental specimens. J. Clin. Microbiol. 1981, 14, 298–303. 
46. Schägger, H.; von Jagow, G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 1987, 166, 368-379. 
47. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of 
protein utilizing the principle of protein–dye binding. Anal. Biochem. 1976, 72, 248–254. 
48. White, J.A.; Hart, R.J.; Fry, J.C. An evaluation of the Waters Pico-Tag system for the amino-acid 
analysis of food materials. J. Automat. Chem. 1986, 8, 170–177.  
© 2012 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/3.0/). 
